Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis

被引:62
作者
Devareddy, Latha
Khalil, Dania A.
Smith, Brenda J.
Lucas, Edralin A.
Soung, Do Y.
Marlow, Denver D.
Arjmandi, Bahram H.
机构
[1] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA
[2] Oklahoma State Univ, Coll Vet Med, Stillwater, OK 74078 USA
关键词
estrogen; isoflavones; microcomputed tomography;
D O I
10.1016/j.bone.2005.10.024
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Soy protein is reported to prevent bone loss in both women and rat models of osteoporosis. However, the role of soy isoflavones on the trabecular microarchitectural properties needs to be explored. In the present study, we examined whether soy protein with graded doses of isoflavones reverses loss of bone mineral density (BMD), bone mineral content (BMC), and trabecular microstructure in an ovariectomized (Ovx) osteopenic rat model. Seventy-eight 9-m old female Sprague-Dawley rats were either sham-operated (Sham; 1 group) or Ovx (5 groups) and fed a semi-purified casein-based diet. After 90 days, the occurrence of bone loss was confirmed using dual energy X-ray absorptiometry. Thereafter, rats were assigned to the following treatments: Sham, Ovx (control), Ovx + 17 beta-estradiol (E-2; 10 mu g/kg body wt. twice per week), Ovx + soy protein depleted of isoflavones (Soy-; 0.06 mg isoflavones/g protein), Ovx + soy protein with normal isoflavone content (Soy; 3.55 mg isoflavones/g protein), and Ovx + isoflavone-enriched soy protein (Soy+; 7.10 mg isoflavones/g protein). After 125 days of treatment, rats were euthanized, and tibia and lumbar bones were collected for the assessment of BMD, BMC, and trabecular rnicroarchitectural properties using X-ray microcomputed tomography. None of the treatments had an effect on BMD or microarchitectural properties of the lumbar vertebra. However, Soy treatment significantly increased tibial BMC and BMD by 10% and 4.5% compared with Ovx control, but the increase in BMD was not enough to reach the BMD levels of the Sham control group. The Soy(+) diet positively affected the tibial architectural properties including trabecular thickness, separation, and number. In summary, our findings suggest that soy protein does not restore bone loss in osteopenic rats; however, higher doses of isoflavones may be required to reverse the loss of tibial microstructural properties. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 63 条
[1]
Alekel DL, 2000, AM J CLIN NUTR, V72, P844
[2]
Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice [J].
Alexander, JM ;
Bab, I ;
Fish, S ;
Müller, R ;
Uchiyama, T ;
Gronowicz, G ;
Nahounou, M ;
Zhao, Q ;
White, DW ;
Chorev, M ;
Gazit, D ;
Rosenblatt, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) :1665-1673
[3]
Colony-stimulating factor-1 stimulates the fusion process in osteoclasts [J].
Amano, H ;
Yamada, S ;
Felix, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (05) :846-853
[4]
One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women [J].
Arjmandi, Bahram H. ;
Lucas, Edralin A. ;
Khalil, Dania A. ;
Devareddy, Latha ;
Smith, Brenda J. ;
McDonald, Jennifer ;
Arquitt, Andrea B. ;
Payton, Mark E. ;
Mason, Claudia .
NUTRITION JOURNAL, 2005, 4 (1)
[5]
Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats [J].
Arjmandi, BH ;
Getlinger, MJ ;
Goyal, NV ;
Alekel, L ;
Hasler, CM ;
Juma, S ;
Drum, ML ;
Hollis, BW ;
Kukreja, SC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1358S-1363S
[6]
The ovarian hormone deficiency-induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone [J].
Arjmandi, BH ;
Khan, DA ;
Juma, SS ;
Svanborg, A .
NUTRITION RESEARCH, 1997, 17 (05) :885-894
[7]
Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis [J].
Arjmandi, BH ;
Alekel, L ;
Hollis, BW ;
Amin, D ;
StacewiczSapuntzakis, M ;
Guo, P ;
Kukreja, SC .
JOURNAL OF NUTRITION, 1996, 126 (01) :161-167
[8]
Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content [J].
Arjmandi, BH ;
Birnbaum, R ;
Goyal, NV ;
Getlinger, MJ ;
Juma, S ;
Alekel, L ;
Hasler, CM ;
Drum, ML ;
Hollis, BW ;
Kukreja, SC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1364S-1368S
[9]
Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion [J].
Arjmandi, BH ;
Khalil, DA ;
Smith, BJ ;
Lucas, EA ;
Juma, S ;
Payton, ME ;
Wild, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1048-1054
[10]
Arjmandi BH., 2001, JANA, V4, P50